Skip to main
GRDN

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Services Inc. is positioned for financial growth due to its strong technological capabilities that enhance value-based care and improve operational efficiency through the integration of tech platforms in newly acquired operations. The company benefits from robust core trends, highlighting an attractive earnings power opportunity, particularly from recently acquired facilities, while its significant market share serves as a key differentiator in the competitive landscape. Furthermore, Guardian’s investment in robotic dispensing technology has demonstrated improved accuracy and efficiency, with an average requisition fulfillment time of under one day, contributing to overall operational effectiveness and cost reduction.

Bears say

The financial outlook for Guardian Pharmacy Services Inc. is negatively impacted by several significant risks, including potential changes in regulations and reimbursement structures, which may adversely affect revenue streams. Additionally, challenges related to managing relationships with long-term care facilities, supply chain disruptions, and difficulties in hiring and retaining qualified clinical staff pose threats to operational stability and growth. Furthermore, the reliance on information technology and the ability to source and integrate acquisitions introduces additional uncertainties that could hinder the company's performance in the competitive healthcare market.

GRDN has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Buy based on their latest research and market trends.

According to 3 analysts, GRDN has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $37.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $37.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.